Literature DB >> 22966041

Kinetics of innate immune response to Yersinia pestis after intradermal infection in a mouse model.

Christopher F Bosio1, Clayton O Jarrett, Donald Gardner, B Joseph Hinnebusch.   

Abstract

A hallmark of Yersinia pestis infection is a delayed inflammatory response early in infection. In this study, we use an intradermal model of infection to study early innate immune cell recruitment. Mice were injected intradermally in the ear with wild-type (WT) or attenuated Y. pestis lacking the pYV virulence plasmid (pYV(-)). The inflammatory responses in ear and draining lymph node samples were evaluated by flow cytometry and immunohistochemistry. As measured by flow cytometry, total neutrophil and macrophage recruitment to the ear in WT-infected mice did not differ from phosphate-buffered saline (PBS) controls or mice infected with pYV(-), except for a transient increase in macrophages at 6 h compared to the PBS control. Limited inflammation was apparent even in animals with high bacterial loads (10(5) to 10(6) CFU). In addition, activation of inflammatory cells was significantly reduced in WT-infected mice as measured by CD11b and major histocompatibility complex class II (MHC-II) expression. When mice infected with WT were injected 12 h later at the same intradermal site with purified LPS, Y. pestis did not prevent recruitment of neutrophils. However, significant reduction in neutrophil activation remained compared to that of PBS and pYV(-) controls. Immunohistochemistry revealed qualitative differences in neutrophil recruitment to the skin and draining lymph node, with WT-infected mice producing a diffuse inflammatory response. In contrast, focal sites of neutrophil recruitment were sustained through 48 h postinfection in pYV(-)-infected mice. Thus, an important feature of Y. pestis infection is reduced activation and organization of inflammatory cells that is at least partially dependent on the pYV virulence plasmid.

Entities:  

Mesh:

Year:  2012        PMID: 22966041      PMCID: PMC3486050          DOI: 10.1128/IAI.00606-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

Review 1.  Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen).

Authors:  Robert R Brubaker
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Experimental comparison of the immunogenicity of antigens in the residue of ultrasonated avirulent Pasteurella pestis with a vaccine prepared with killed virulent whole organisms.

Authors:  T H CHEN; L E FOSTER; K F MEYER
Journal:  J Immunol       Date:  1961-07       Impact factor: 5.422

3.  Allergy to flea bites. I. Experimental induction of flea-bite sensitivity in guinea pigs.

Authors:  B W HUDSON; B F FEINGOLD; L KARTMAN
Journal:  Exp Parasitol       Date:  1960-02       Impact factor: 2.011

4.  Expression of activation molecules in neutrophils, monocytes and lymphocytes from patients with unstable angina treated with stent implantation.

Authors:  Víctor Sánchez-Margalet; José M Cubero; Consuelo Martín-Romero; José Cubero; José M Cruz-Fernández; Raimundo Goberna
Journal:  Clin Chem Lab Med       Date:  2004-03       Impact factor: 3.694

5.  Transcriptomic and innate immune responses to Yersinia pestis in the lymph node during bubonic plague.

Authors:  Jason E Comer; Daniel E Sturdevant; Aaron B Carmody; Kimmo Virtaneva; Donald Gardner; Dan Long; Rebecca Rosenke; Stephen F Porcella; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

6.  Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague.

Authors:  Florent Sebbane; Clayton O Jarrett; Donald Gardner; Daniel Long; B Joseph Hinnebusch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

7.  Quantitative competitive PCR as a technique for exploring flea-Yersina pestis dynamics.

Authors:  D M Engelthaler; B J Hinnebusch; C M Rittner; K L Gage
Journal:  Am J Trop Med Hyg       Date:  2000-05       Impact factor: 2.345

8.  Yersinia pestis type III secretion system-dependent inhibition of human polymorphonuclear leukocyte function.

Authors:  Justin L Spinner; Jennifer A Cundiff; Scott D Kobayashi
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

Review 9.  Innate immune response during Yersinia infection: critical modulation of cell death mechanisms through phagocyte activation.

Authors:  Tessa Bergsbaken; Brad T Cookson
Journal:  J Leukoc Biol       Date:  2009-09-04       Impact factor: 4.962

10.  Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.

Authors:  R Nakajima; R R Brubaker
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

View more
  19 in total

1.  Comparison of Models for Bubonic Plague Reveals Unique Pathogen Adaptations to the Dermis.

Authors:  Rodrigo J Gonzalez; Eric H Weening; M Chelsea Lane; Virginia L Miller
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

2.  Redundant and Cooperative Roles for Yersinia pestis Yop Effectors in the Inhibition of Human Neutrophil Exocytic Responses Revealed by Gain-of-Function Approach.

Authors:  Amanda R Pulsifer; Aruna Vashishta; Shane A Reeves; Jennifer K Wolfe; Samantha G Palace; Megan K Proulx; Jon Goguen; Sobha R Bodduluri; Bodduluri Haribabu; Silvia M Uriarte; Matthew B Lawrenz
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

Review 3.  YopJ Family Effectors Promote Bacterial Infection through a Unique Acetyltransferase Activity.

Authors:  Ka-Wai Ma; Wenbo Ma
Journal:  Microbiol Mol Biol Rev       Date:  2016-10-26       Impact factor: 11.056

4.  Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major.

Authors:  Flavia L Ribeiro-Gomes; Eric Henrique Roma; Matheus B H Carneiro; Nicole A Doria; David L Sacks; Nathan C Peters
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

5.  A Deadly Path: Bacterial Spread During Bubonic Plague.

Authors:  Rodrigo J Gonzalez; Virginia L Miller
Journal:  Trends Microbiol       Date:  2016-02-12       Impact factor: 17.079

6.  Role of Yersinia pestis toxin complex family proteins in resistance to phagocytosis by polymorphonuclear leukocytes.

Authors:  Justin L Spinner; Aaron B Carmody; Clayton O Jarrett; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2013-08-19       Impact factor: 3.441

7.  Reevaluation of the Role of Blocked Oropsylla hirsuta Prairie Dog Fleas (Siphonaptera: Ceratophyllidae) in Yersinia pestis (Enterobacterales: Enterobacteriaceae) Transmission.

Authors:  Adélaïde Miarinjara; David A Eads; David M Bland; Marc R Matchett; Dean E Biggins; B Joseph Hinnebusch
Journal:  J Med Entomol       Date:  2022-05-11       Impact factor: 2.435

8.  Role of the Yersinia YopJ protein in suppressing interleukin-8 secretion by human polymorphonuclear leukocytes.

Authors:  Justin L Spinner; Aaron M Hasenkrug; Jeffrey G Shannon; Scott D Kobayashi; B Joseph Hinnebusch
Journal:  Microbes Infect       Date:  2015-09-08       Impact factor: 2.700

9.  Yersinia pestis survival and replication within human neutrophil phagosomes and uptake of infected neutrophils by macrophages.

Authors:  Justin L Spinner; Seth Winfree; Tregei Starr; Jeffrey G Shannon; Vinod Nair; Olivia Steele-Mortimer; B Joseph Hinnebusch
Journal:  J Leukoc Biol       Date:  2013-11-13       Impact factor: 4.962

10.  Metallacarborane Derivatives Effective against Pseudomonas aeruginosa and Yersinia enterocolitica.

Authors:  Wieslaw Swietnicki; Waldemar Goldeman; Mateusz Psurski; Anna Nasulewicz-Goldeman; Anna Boguszewska-Czubara; Marek Drab; Jordan Sycz; Tomasz M Goszczyński
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.